Efficacy and Renal Toxicity of One Daily Dose of Amikacin versus Conventional Dosage Regime

ABSTRACT

This study assessed the efficacy and renal toxicity of one daily dose of amikacin versus several doses in infected full-term newborns. A clinical trial was conducted with 120 patients who were divided into two groups: group A (n = 60), infants who received amikacin 20 mg/kg/d in one dose; and group B (n = 60), infants who received amikacin 10 mg/kg/d every 12 hours. Both groups also received ampicillin 100 mg/kg/day. Blood levels of amikacin, urinary β₂-microglobulin (β₂-m), serum creatinine (SCr), and glomerular filtration rate (GFR) were measured in each patient. No significant difference was found in demographic characteristics as well as in their β₂-m, SCr, and GFR levels. Infection was resolved in 96% for infants of group A and 91% for group B (p = 0.254). Renal toxicity was present in 20 versus 31.6%, respectively (p = 0.211). In both groups no significant difference was found in peak amikacin levels, whereas trough levels were higher for group B (p = 0.004). No significant difference was found in efficacy or renal toxicity in either group. We recommend using amikacin in one daily dose. It could diminish the manipulation of intravenous access, reducing the risk of nosocomial infections.

KEYWORDS

Amikacin - renal toxicity - efficacy - full-term newborns

REFERENCES

• 1 Freij B J, McCracken Jr G H. Acute infections. In: Avery GB, Fletcher MA, McDonald MG Neonatology: Pathophysiology and Management of the Newborn. 5th ed. Philadelphia, PA; Lippincott Williams & Wilkins 1999: 1189-1230
• 2 Klein J O, Marcy M. Bacterial sepsis and meningitis. In: Remington JS, Klein JO Infectious Diseases of the Fetus Newborn Infant. 4th ed. Philadelphia, PA; W.B. Saunders 1995: 835-890
• 3 Gonzalez L S, Spencer J P. Aminoglycosides: a practical review.  Am Fam Physician. 1998;  58 1811-1820
• 4 Bailey T C, Little J R, Littenberg B A. Meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.  Clin Infect Dis. 1997;  24 786-795
• 5 Barza M, Loannidis P A, Cappelleri J, Lau J. Single or multiple daily doses of aminoglycosides: a meta-analysis.  BMJ. 1996;  312 338-343
• 6 Munckhof W J, Grayson L, Turnidge J. A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses.  J Antimicrob Chemother. 1996;  37 645-663
• 7 Beaucaire G, Leroy O, Beuscart C, Karp P, Chidiac C, Caillaux M. Clinical and bacteriological efficacy and practical aspects of amikacin given once daily for severe infections.  J Antimicrob Chemother. 1991;  27 Suppl C 91-103
• 8 Solórzano-Santos F, Miranda-Novales M G, Díaz-Peña R et al.. Amikacina en dosis única diaria en niños neutropénicos con fiebre.  Rev Invest Clin. 1996;  48 13-18
• 9 Forsyth N B, Botha J H, Hadley G P. A comparison of two amikacin dosing regimens in paediatric surgical patients.  Ann Trop Paediatr. 1997;  17 253-261
• 10 Stickland M D, Kirkpatrick C MJ, Begg E J, Duffull S B, Oddie S J, Darlow B A. An extended interval dosing method for gentamicin in neonates.  J Antimicrob Chemother. 2001;  48 887-893
• 11 De Alba Romero C, Castillo E G, Secades C M, López J R, López L A, Valiente P S. Once daily gentamicin dosing in neonatos.  Pediatr Infect Dis J. 1998;  17 1169-1171
• 12 Kotze A, Bartel P, Sommers K. Once versus twice daily amikacin in neonates: prospective study on toxicity.  J Paediatr Child Health. 1999;  35 283-286
• 13 Manroe B L, Weiber A G, Rosenfield C R, Brown R. The neonatal blood count in health and disease: reference values for neutrophilic cell.  J Pediatr. 1979;  95 89-98
• 14 Rodwell R L, Leslie A L, Tudehope D I. Early diagnosis of neonatal sepsis using a hematologic scoring system.  J Pediatr. 1988;  112 761-767
• 15 In: Avery GB, Fletcher MA, McDonald MG Neonatology: Pathophysiology and Management of the Newborn. 5th ed. Philadelphia, PA; Lippincott Williams & Wilkins 1999: 1499-1564
• 16 Kafetzis D, Sianidou L, Vlachos E et al.. Clinical and pharmacokinetic study of a single daily dose of amikacin in paediatric patients with sever gram-negative infections.  J Antimicrob Chemother. 1991;  27 Suppl C 105-112
• 17 Gouyon J B, Guignard J P. Management of acute renal failure in newborns.  Pediatr Nephrol. 2000;  14 1037-1044
• 18 Fanos V, Mussap M, Verlato G, Plebani M, Padovani E M. Evaluation of antibiotic-induced nephrotoxicity in preterm neonates by determining urinary α₁-microglobulin.  Pediatr Nephrol. 1996;  10 645-647
• 19 Giapros V I, Andronikou S, Cholevas V I. Renal function in premature infants during aminoglycoside therapy.  Pediatr Nephrol. 1995;  9 163-166
• 20 Schwartz G J, Brion L P, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents.  Pediatr Clin North Am. 1987;  34 571-590
• 21 Van Den Anker J N, Van Der Heijden B J, Hop W CJ, Lindemans J. Assessment of glomerular filtration rate in preterm infants by serum creatinine: Comparison with inulin clearance.  Pediatrics. 1995;  96 1156-1158
• 22 Langhendries J P, Battisti O, Bertrand J M et al.. Once-a-day administration of amikacin in neonates: assessment of nephrotoxicity and ototoxicity.  Dev Pharmacol Ther. 1993;  20 220-230